Drug survival for azathioprine and enteric‐coated mycophenolate sodium in a long‐term daily practice cohort of adult patients with atopic dermatitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug survival for azathioprine and enteric‐coated mycophenolate sodium in a long‐term daily practice cohort of adult patients with atopic dermatitis

Published:2016-04-17 Issue:1 Volume:175 Page:199-202
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Schaft J.¹,Politiek K.²,Reek J.M.P.A.³,Kievit W.⁴,Jong E.M.G.J.³,Bruijnzeel‐Koomen C.A.F.M.¹,Schuttelaar M.L.A.²,Bruin‐Weller M.S.¹

Affiliation:

1. Department of Dermatology and Allergology University Medical Center Utrecht Utrecht the Netherlands

2. Department of Dermatology University Medical Center Groningen Groningen the Netherlands

3. Department of Dermatology Radboud University Nijmegen Medical Centre Radboud the Netherlands

4. Department of Health Evidence Radboud University Nijmegen Medical Centre Radboud the Netherlands

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.14398

Reference9 articles.

1. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial

2. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial

3. A randomized trial of methotrexate versus azathioprine for severe atopic eczema

4. First experience with enteric-coated mycophenolate sodium (Myfortic®) in severe recalcitrant adult atopic dermatitis: an open label study

5. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: A randomized controlled trial

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized controlled trials;Advances in Dermatology and Allergology;2022

2. Drug survival of systemic immunosuppressive treatments for atopic dermatitis in a long-term pediatric cohort;International Journal of Women's Dermatology;2021-12

3. Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results;Journal of Allergy and Clinical Immunology;2021-08

4. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial;The Lancet;2021-06

5. Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry;Journal of the American Academy of Dermatology;2021-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3